Document Type

Poster

Publication Date

Spring 2014

Comments

Presented at the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT). Milan Italy March 30-April 2 2014

Abstract

Introduction:

HSCT is a curative option for many patients (pts) with hematological malignancies.

Significant advances in supportive care and conditioning regimens over the past decade have allowed the extension of this therapy to older individuals.

Information regarding the outcomes of this older subset of pts undergoing HSCT is limited, especially those undergoing haploidential (HI) HSCT.

Objectives:

To describe the outcomes of patients 60 years of age or older undergoing haploidential and matched related (MR) HSCT using the 2-step approach.

Included in

Oncology Commons

Share

COinS